The abstract is read at the publisher; the summary is JClub's.
Targeting H3K9me3 with F5446 suppresses colon tumor liver metastasis in a syngeneic mouse model by shifting exhausted Tex cells toward IFNγhighPD-1low and IFNγhigh Tex-int states.
- Why it matters: Colon cancer liver metastasis drives most mortality, yet liver metastases show no response to anti-PD-1 or CTL adoptive transfer, leaving a gap for therapies that reinvigorate tumor-infiltrating T cells.
- What they did: In mice bearing colon tumor liver metastases, the H3K9me3-specific histone methyltransferase inhibitor F5446 was tested, alongside scRNA-seq to track PD-1+Tim3+ Tex differentiation; human relevance was assessed using liver metastasis scRNA-seq and humanized PDX models.
- The result: F5446 increased IFNγhighPD-1low Tex cells in mice and raised IFNγhigh intermediate Tex cells while suppressing PDX growth in humanized mice, and human pembrolizumab response correlated with tumor-infiltrating IFNγhigh Tex cells.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.